Caricamento...
The Standard of Care for Immune Thrombotic Thrombocytopenic Purpura Today
Targeted therapy of immune thrombotic thrombocytopenic purpura (iTTP) requires acurate and prompt diagnosis and differentiation from complement-mediated hemolytic uremic syndrome and other causes of thrombotic microangiopathy. ADAMTS13 evaluation (activity and inhibitors or anti-ADAMTS13 IgG) is the...
Salvato in:
| Pubblicato in: | J Thromb Haemost |
|---|---|
| Autore principale: | |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2021
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8324529/ https://ncbi.nlm.nih.gov/pubmed/34060225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jth.15406 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|